Corporate Finance

The luxury outerwear brand's upcoming earnings will show if its strategic pivot and DTC push delivered during the crucial holiday season amid economic headwinds.

A record drop in inventory fueled by high-end holiday spending reveals a fragile economy, with logistics data pointing to a turbulent year ahead for business.

Granddaughter of an icon, dressage champion Athena Hepburn partners with FESA to tackle equestrian sport's biggest challenges: welfare and sustainability.

Activist investor Elliott challenges Toyota's bid to take Toyota Industries private, demanding a much higher price and setting up a major shareholder showdown.

French innovator Hoffmann Green expands its low-carbon cement licensing to the US West, signaling a major push into America's booming green building market.

Facing revenue decline from new regulations, Pet Service Holding partners with Figo to tap the booming, underserved European pet insurance market.

Merck's former R&D IT head Matt Studney joins TetraScience, a move highlighting biopharma's critical pivot from fragmented data to industrial-scale AI.

With Asia's largest digital bank funding of 2025, WeLab plans a major AI-driven expansion into Southeast Asia, backed by global financial giants.

International Healthcare Week 2026 will unite pharma, medtech, and labs, aiming to transform healthcare for 700 million people across Southeast Asia.

A Markham manufacturer is tripling its transformer production, creating 150 jobs and tackling a critical shortage threatening North America's energy future.

Golconda Gold appoints a new GM to restart its New Mexico mine, a strategic move to unlock over 1M ounces of annual silver production and diversify its portfolio.

UiPath's agentic AI, powered by Claude Opus 4.5, has secured the top spot on a crucial industry benchmark, validating its enterprise-readiness.

GCE sets its Q4 earnings date. Investors eye enrollment, margins, and its 2026 outlook as the education services giant navigates a shifting market.

As Helmerich & Payne preps its Q1 2026 earnings call, investors are watching if its tech focus can overcome soft rig demand and cautious market signals.

Flashpoint Therapeutics appoints an FDA-approved drug developer as CSO, a strategic move to accelerate its groundbreaking structural nanomedicine platform.

Viking dominates the USA TODAY 10BEST awards, proving its destination-focused, adults-only strategy is redefining luxury travel for modern cruisers.

Top 25 firm Aprio unveils its 'Account for Anything™' rebrand, signaling a strategic pivot to integrated advisory in an increasingly complex market.

A new synthetic bone graft powered by NanoLift™ technology promises to accelerate healing and improve outcomes for orthopedic and spinal surgery patients.

With 15,000 patients served and a 75% in-person preference, SOL Mental Health's 2025 growth shows a powerful demand for local, data-driven care.

The iconic backpack brand launches its Lunar Lounge Collection, betting on durability and sustainability to conquer the crowded $1.8 trillion wellness market.